Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus.
Ronald F Van VollenhovenKenneth C KalunianThomas DörnerBevra H HahnYoshiya TanakaRobert M GordonCathye ShuKaiyin FeiSheng GaoLoqmane SeridiPatrick GallagherKim Hung LoPamela BerryQing C ZurawPublished in: Annals of the rheumatic diseases (2022)
NCT03517722.